• Exchange: Stockholm
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma


100.2000 SEK 2.5000 2.43%

As of 11:29:59 ET on 09/23/2014.

Snapshot for Meda AB (MEDAA)

Open: 102.7000 Day's Range: 99.6000 - 103.2000 Volume: 1,495,966
Previous Close: 102.7000 52wk Range: 69.7000 - 129.9000 1-Yr Rtn: +34.28%

Stock Chart for MEDAA

No chart data available.
  • MEDAA:SS 100.2000
  • 1D
  • 1M
  • 1Y
Interactive MEDAA Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for MEDAA

Current P/E Ratio (ttm) 33.4775
Estimated P/E(12/2014) 10.8677
Relative P/E vs. OMX 2.0806
Earnings Per Share (SEK) (ttm) 2.9931
Est. EPS (SEK) (12/2014) 9.2200
Est. PEG Ratio 0.4225
Market Cap (M SEK) 30,284.76
Shares Outstanding (M) 302.24
30 Day Average Volume 1,250,435
Price/Book (mrq) 1.9749
Price/Sale (ttm) 2.2470
Dividend Indicated Gross Yield 2.50%
Cash Dividend (SEK) 2.5000
Dividend Ex-Date 05/08/2014
5 Year Dividend Growth 27.23%
Next Earnings Announcement 11/06/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for MEDAA

  • Revenue
  • Net Income (M/SEK)
  • Profit Margin (%)

Company Profile & Key Executives for MEDAA

Meda AB is a specialty pharmaceutical company. The Company imports and markets pharmaceuticals, nutritional, and health-care products, and offers services including clinical research, registration, and logistics. Meda's products are sold in the Nordic countries and in the Baltic states on behalf of foreign manufacturers. The Company markets to wholesale dealers and hospitals.

Henrik StenqvistExec VP/CFOMaria CarellExec VP:North America
Dirk GroenExec VP:Marketing OTCErik HaefflerExec VP:Manufacturing
More Company Profile & Key Executives for MEDAA

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil